These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34414930)

  • 1. A literature review of consent declines and consent withdrawals in randomized controlled trials conducted during the COVID-19 pandemic.
    Gogtay NJ; Sheth HJ; Maurya MR; Belhekar MN; Thatte UM
    J Postgrad Med; 2021; 67(3):134-138. PubMed ID: 34414930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of interventions for informed consent for randomised controlled trials (ELICIT): protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Gillies K; Entwistle V; Treweek SP; Fraser C; Williamson PR; Campbell MK
    Trials; 2015 Oct; 16():484. PubMed ID: 26507504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review.
    Flory JH; Mushlin AI; Goodman ZI
    J Gen Intern Med; 2016 Dec; 31(12):1511-1518. PubMed ID: 27384536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
    Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
    BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials.
    Emanuel EJ; Boyle CW
    JAMA Netw Open; 2021 Apr; 4(4):e2110843. PubMed ID: 33909052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reopening schools safely in the face of COVID-19: Can cluster randomized trials help?
    Weijer C; Hemming K; Phillips Hey S; Fernandez Lynch H
    Clin Trials; 2021 Jun; 18(3):371-376. PubMed ID: 33472432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient advocacy and patient centredness in participant recruitment to randomized-controlled trials: implications for informed consent.
    Tomlin Z; deSalis I; Toerien M; Donovan JL
    Health Expect; 2014 Oct; 17(5):670-82. PubMed ID: 22712887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials.
    Behrendt C; Gölz T; Roesler C; Bertz H; Wünsch A
    J Med Ethics; 2011 Feb; 37(2):74-80. PubMed ID: 21098797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.
    Narayanan S; Chua JV; Heil E
    J Gen Intern Med; 2020 Nov; 35(11):3359-3360. PubMed ID: 32885370
    [No Abstract]   [Full Text] [Related]  

  • 12. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking Consent for Stroke Trials in Time-Sensitive Situations: Insights From the COVID-19 Pandemic.
    Goyal M; Ospel JM; Ganesh A; Marko M; Fisher M
    Stroke; 2021 Apr; 52(4):1527-1531. PubMed ID: 33588599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).
    Wade J; Elliott D; Avery KNL; Gaunt D; Young GJ; Barnes R; Paramasivan S; Campbell WB; Blazeby JM; Birtle AJ; Stein RC; Beard DJ; Halliday AW; Donovan JL; ; ; ; ; ;
    Trials; 2017 Jul; 18(1):327. PubMed ID: 28716064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ethics of cluster-randomized trials requires further evaluation: a refinement of the Ottawa Statement.
    van der Graaf R; Koffijberg H; Grobbee DE; de Hoop E; Moons KG; van Thiel GJ; de Wit GA; van Delden JJ
    J Clin Epidemiol; 2015 Sep; 68(9):1108-14. PubMed ID: 25910909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review.
    O'Sullivan L; Killeen RP; Doran P; Crowley RK
    BMC Med Ethics; 2021 Jun; 22(1):80. PubMed ID: 34182962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed surgical consent during the COVID-19 pandemic: Exploring the risk of unknown-Update of informed consent form.
    Wainstein AJA; Drummond-Lage AP; Ribeiro R; de Castro Ribeiro HS; Pinheiro RN; Oliveira AF
    J Surg Oncol; 2020 Nov; 122(6):1259. PubMed ID: 32786075
    [No Abstract]   [Full Text] [Related]  

  • 20. Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies.
    Nix HP; Weijer C
    BMC Med Ethics; 2021 Oct; 22(1):143. PubMed ID: 34674679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.